|
시장보고서
상품코드
1762497
세계의 고셔병 치료 시장 : 시장 규모, 점유율 및 동향, 업계 분석(유형별, 치료법별, 유통 채널별, 지역별), 예측(2025-2034년)Gaucher Disease Treatment Market Size, Share, Trends, & Industry Analysis Report: By Type (Type 1, Type 3, Type 2), By Therapy, By Distribution Channel, and By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면, 세계 고셔병 치료제 시장 규모는 2034년까지 21억 달러에 달할 것으로 예측됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.
고셔병은 가장 흔한 리포솜 저장 장애 중 하나로, 지방 화합물, 특히 글루코세레브로시드를 분해하는 효소인 글루코세레브로시다아제의 결핍으로 인해 발생합니다. 이 효소 결핍은 글루코세레브로사이드의 축적으로 이어져 비장, 간, 골수에 고셰 세포가 형성됩니다. 이 질환은 주로 비장 및 간 부종, 피로, 빈혈, 뼈의 불편감 및 골절, 출혈 등의 증상을 특징으로 합니다.
희귀 유전질환인 고셔병의 진단과 치료는 이 질환에 대한 인식이 높아짐에 따라 발전하고 있습니다. 인지도가 높아짐에 따라 더 많은 사람들이 조기에 진단을 받고 질병을 더 잘 관리할 수 있게 되었습니다. 이러한 발전은 인식 제고 캠페인, 검진 강화, 의료 전문가에 대한 교육 강화가 뒷받침하고 있습니다. 또한, 유병률이 높은 지역에서 신생아 검진 프로그램을 확대하고 우선순위를 정함으로써 조기 발견과 적시 치료를 크게 개선하고 있습니다.
고셔병 치료제 시장은 또한 미국 식품의약국(FDA)의 의약품 승인 수가 증가함에 따라 주요 시장 기업들이 의약품 개발에 혁신적인 전략을 채택하도록 유도하고 있습니다. 또한, 바이오 의약품과 연구 기관의 공동 연구는 향후 몇 년 동안 시장 성장을 가속화할 것으로 예측됩니다.
고셔병 치료제 시장의 경쟁은 주요 기업들이 보다 새롭고 효과적인 치료법 개발을 위해 끊임없이 노력하고 있음을 보여줍니다. 각 업체들은 환자의 예후 개선에 대한 수요 증가에 부응하기 위해 치료법을 발전시키고 기존 치료법의 대안을 모색하는 데 주력하고 있습니다.
고셔병 치료제 시장 : 분석 개요
치료법별로는 효소대체요법이 2024년 매출 점유율 67.9%를 차지하며 시장을 독점했습니다.
유형별로는 고셔병에서 가장 흔하게 발병하는 유형인 1형이 환자 수 증가로 2024년 매출 점유율 75%로 시장을 주도했습니다.
북미는 고셔병에 대한 인식 개선, 의료 인프라 강화, 신약 개발 및 연구 활동의 활성화로 2024년 매출 점유율 47.4%로 세계 시장을 독식했습니다.
아시아태평양은 예측 기간 동안 가장 빠른 성장을 기록할 것으로 예측됩니다. 이 지역의 견조한 성장은 의료 인프라의 개선과 희귀질환 및 생명을 위협하는 질병에 대한 인식을 높이기 위한 정부의 이니셔티브에 기인합니다.
고셔병 치료제 시장의 주요 기업으로는 화Pfizer Inc.; Janssen Pharmaceuticals; JCR Pharmaceuticals Co Ltd.; Sanofi Genzyme; Takeda Pharmaceuticals; Johnson & Johnson Services, Inc.; Shire Human Genetics Therapies, Inc.; Erad Therapeutic Inc.; ERAD Therapeutics.등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 분석 방법
제4장 세계의 고셔병 치료 시장 인사이트
- 시장 현황
- 고셔병 치료 시장 역학
- 성장 촉진요인과 기회
- 성장 억제요인과 과제
- PESTLE 분석
- 고셔병 치료 시장 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 고셔병 치료 시장 : 유형별
- 주요 분석 결과
- 서론
- 1형
- 3형
- 2형
제6장 세계의 고셔병 치료 시장 : 치료법별
- 주요 분석 결과
- 서론
- 효소 보충 요법(ERT)
- 기질 감소 요법(SRT)
- 기타
제7장 세계의 고셔병 치료 시장 : 유통 채널별
- 주요 분석 결과
- 서론
- 병원 약국
- 소매 약국
- 온라인 약국
제8장 세계의 고셔병 치료 시장 : 지역별
- 주요 분석 결과
- 서론
- 고셔병 치료 시장 분석 : 지역별(2020-2034년)
- 북미
- 북미 : 유형별(2020-2034년)
- 북미 : 치료법별(2020-2034년)
- 북미 : 유통 채널별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 유형별(2020-2034년)
- 유럽 : 치료법별(2020-2034년)
- 유럽 : 유통 채널별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 유형별(2020-2034년)
- 아시아태평양 : 치료법별(2020-2034년)
- 아시아태평양 : 유통 채널별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별(2020-2034년)
- 중동 및 아프리카 : 치료법별(2020-2034년)
- 중동 및 아프리카 : 유통 채널별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 유형별, 2020-2034년
- 라틴아메리카 : 치료법별(2020-2034년)
- 라틴아메리카 : 유통 채널별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 사업 확대 및 기업 인수 분석
- 사업 확대
- 기업 인수
- 제휴/협업/합의/공개
제10장 기업 개요
- Amicus Therapeutics, Inc.
- CANbridge Life Sciences Ltd.
- Eli Lilly and Company
- Johnson & Johnson, Inc.
- Lingyi Biotechnology
- Protalix Biotherapeutics Inc.
- Sanofi
- Spur Therapeutics
- Takeda Pharmaceutical
The global Gaucher disease treatment market size is expected to reach USD 2.10 billion by 2034, according to a new study by Polaris Market Research. The report "Gaucher Disease Treatment Market Size, Share, Trends, Industry Analysis Report: By Therapy (Substrate Replacement Therapy, Enzyme Replacement Therapy, and Others), Type, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Gaucher disease is one of the most common liposomal storage disorders, caused by a deficiency of glucocerebrosidase, an enzyme responsible for breaking down fatty compounds, specifically glucocerebroside. This enzyme deficiency leads to the accumulation of glucocerebroside, resulting in the formation of Gaucher cells in the spleen, liver, and bone marrow. This condition is primarily characterized by symptoms such as an enlarged spleen or liver, fatigue, anemia, bone discomfort and fractures, and bleeding.
The diagnosis and treatment of Gaucher disease, a rare genetic disorder, are evolving due to increasing awareness of the condition. With greater awareness, more individuals are receiving earlier diagnoses, leading to improved disease management. Awareness campaigns, enhanced screening initiatives, and increased training for healthcare professionals support this progress. Additionally, the expansion and prioritization of newborn screening programs in regions with higher prevalence are significantly improving early identification and timely treatment.
The Gaucher disease treatment market is also driven by an increasing number of drug approvals from the US Food and Drug Administration (FDA), encouraging leading market players to adopt innovative strategies in drug development. Additionally, collaborations between biopharmaceutical and research institutions are expected to accelerate market growth in the coming years.
The competitive nature of the Gaucher disease treatment market highlights that leading players are constantly seeking to develop more novel and effective treatment alternatives. Companies are focused on advancing medical therapies and exploring alternatives to existing treatments, aiming to meet the growing demand for improved patient outcomes.
Key Highlights of Gaucher Disease Treatment Market Report
Based on therapy, the enzyme replacement therapy segment dominated the market with a 67.9% revenue share in 2024, driven by the high number of FDA-approved medications for the therapy.
By type, the Type 1 segment led the market with a 75% revenue share in 2024 due to a rise in patient occurrence, as this is the most commonly occurring type of Gaucher's disease.
North America dominated the global market with a 47.4% revenue share in 2024, driven by greater awareness of Gaucher disease, enhanced healthcare infrastructure, and increasing drug discovery and research activities.
Asia Pacific is expected to register the fastest growth during the forecast period. The region's robust growth is attributed to improved healthcare infrastructure and government efforts to raise awareness about rare and life-threatening diseases.
Key players in the Gaucher disease treatment market include Pfizer Inc.; Janssen Pharmaceuticals; JCR Pharmaceuticals Co Ltd.; Sanofi Genzyme; Takeda Pharmaceuticals; Johnson & Johnson Services, Inc.; Shire Human Genetics Therapies, Inc.; Erad Therapeutic Inc.; and ERAD Therapeutics.
Polaris Market Research has segmented the Gaucher disease treatment market report on the basis of therapy, type, and region:
Gaucher Disease Treatment Market Segmentation
By Therapy Outlook (Revenue - USD Billion, 2020-2034)
Substrate Replacement Therapy
Enzyme Replacement Therapy
Others
By Type Outlook (Revenue - USD Billion, 2020-2034)
Type 1
Type 2
Type 3
Others
By Regional Outlook (Revenue - USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of the Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Gaucher Disease Treatment Market Report Scope
Report Attributes
Details
Market Size Value in 2024
USD 1.64 billion
Market Size Value in 2025
USD 1.67 billion
Revenue Forecast by 2034
USD 2.10 billion
CAGR
- 2.54% from 2025 to 2034
Base Year
2024
Historical Data
2020-2023
Forecast Period
2025-2034
Quantitative Units
Revenue in USD billion and CAGR from 2025 to 2034
Report Coverage
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered
By Therapy
By Type
Regional Scope
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Competitive Landscape
Gaucher Disease Treatment Industry Trends Analysis (2024)
Company profiles/industry participants profiling includes company overview, financial information, product/service benchmarking, and recent developments
Report Format
PDF + Excel
Customization
Report customization as per your requirements with respect to countries, regions, and segmentation.
For Specific Research Requirements
Request for Customized Report
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Gaucher Disease Treatment Market Insights
- 4.1. Gaucher Disease Treatment Market - Market Snapshot
- 4.2. Gaucher Disease Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Healthcare Spending
- 4.2.1.2. Increasing Strategic Collaboration, Acquisition, and Partnership
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Initial Cost of Manufacturing
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Gaucher Disease Treatment Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Gaucher Disease Treatment Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 5.3. Type 1
- 5.3.1. Global Gaucher Disease Treatment Market, by Type 1, by Region, 2020-2034 (USD Billion)
- 5.4. Type 3
- 5.4.1. Global Gaucher Disease Treatment Market, by Type 3, by Region, 2020-2034 (USD Billion)
- 5.5. Type 2
- 5.5.1. Global Gaucher Disease Treatment Market, by Type 2, by Region, 2020-2034 (USD Billion)
6. Global Gaucher Disease Treatment Market, by Therapy
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 6.3. Enzyme Replacement Therapy (ERT)
- 6.3.1. Global Gaucher Disease Treatment Market, by Enzyme Replacement Therapy (ERT), by Region, 2020-2034 (USD Billion)
- 6.4. Substrate Reduction Therapy (SRT)
- 6.4.1. Global Gaucher Disease Treatment Market, by Substrate Reduction Therapy (SRT), by Region, 2020-2034 (USD Billion)
- 6.5. Others
- 6.5.1. Global Gaucher Disease Treatment Market, by Others, by Region, 2020-2034 (USD Billion)
7. Global Gaucher Disease Treatment Market, by Distribution Channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.3. Hospital Pharmacies
- 7.3.1. Global Gaucher Disease Treatment Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
- 7.4. Retail Pharmacies
- 7.4.1. Global Gaucher Disease Treatment Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
- 7.5. Online Pharmacies
- 7.5.1. Global Gaucher Disease Treatment Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)
8. Global Gaucher Disease Treatment Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Gaucher Disease Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
- 8.3. Gaucher Disease Treatment Market - North America
- 8.3.1. North America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.3.3. North America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.4. Gaucher Disease Treatment Market - U.S.
- 8.3.4.1. U.S.: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.3.4.2. U.S.: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.3.4.3. U.S.: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.5. Gaucher Disease Treatment Market - Canada
- 8.3.5.1. Canada: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.3.5.2. Canada: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.3.5.3. Canada: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4. Gaucher Disease Treatment Market - Europe
- 8.4.1. Europe: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.3. Europe: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.4. Gaucher Disease Treatment Market - UK
- 8.4.4.1. UK: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.4.4.2. UK: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.4.3. UK: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.5. Gaucher Disease Treatment Market - France
- 8.4.5.1. France: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.4.5.2. France: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.5.3. France: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.6. Gaucher Disease Treatment Market - Germany
- 8.4.6.1. Germany: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.4.6.2. Germany: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.6.3. Germany: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.7. Gaucher Disease Treatment Market - Italy
- 8.4.7.1. Italy: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.4.7.2. Italy: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.7.3. Italy: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.8. Gaucher Disease Treatment Market - Spain
- 8.4.8.1. Spain: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.4.8.2. Spain: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.8.3. Spain: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.9. Gaucher Disease Treatment Market - Netherlands
- 8.4.9.1. Netherlands: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.4.9.2. Netherlands: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.9.3. Netherlands: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.10. Gaucher Disease Treatment Market - Russia
- 8.4.10.1. Russia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.4.10.2. Russia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.10.3. Russia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.11. Gaucher Disease Treatment Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5. Gaucher Disease Treatment Market - Asia Pacific
- 8.5.1. Asia Pacific: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.4. Gaucher Disease Treatment Market - China
- 8.5.4.1. China: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.5.4.2. China: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.4.3. China: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.5. Gaucher Disease Treatment Market - India
- 8.5.5.1. India: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.5.5.2. India: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.5.3. India: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.6. Gaucher Disease Treatment Market - Malaysia
- 8.5.6.1. Malaysia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.5.6.2. Malaysia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.6.3. Malaysia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.7. Gaucher Disease Treatment Market - Japan
- 8.5.7.1. Japan: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.5.7.2. Japan: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.7.3. Japan: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.8. Gaucher Disease Treatment Market - Indonesia
- 8.5.8.1. Indonesia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.5.8.2. Indonesia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.8.3. Indonesia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.9. Gaucher Disease Treatment Market - South Korea
- 8.5.9.1. South Korea: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.5.9.2. South Korea: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.9.3. South Korea: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.10. Gaucher Disease Treatment Market - Australia
- 8.5.10.1. Australia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.5.10.2. Australia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.10.3. Australia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.11. Gaucher Disease Treatment Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6. Gaucher Disease Treatment Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.4. Gaucher Disease Treatment Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.5. Gaucher Disease Treatment Market - UAE
- 8.6.5.1. UAE: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.6.5.2. UAE: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.6.5.3. UAE: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.6. Gaucher Disease Treatment Market - Israel
- 8.6.6.1. Israel: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.6.6.2. Israel: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.6.6.3. Israel: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.7. Gaucher Disease Treatment Market - South Africa
- 8.6.7.1. South Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.6.7.2. South Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.6.7.3. South Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.8. Gaucher Disease Treatment Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7. Gaucher Disease Treatment Market - Latin America
- 8.7.1. Latin America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.4. Gaucher Disease Treatment Market - Mexico
- 8.7.4.1. Mexico: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.7.4.2. Mexico: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.7.4.3. Mexico: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.5. Gaucher Disease Treatment Market - Brazil
- 8.7.5.1. Brazil: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.7.5.2. Brazil: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.7.5.3. Brazil: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.6. Gaucher Disease Treatment Market - Argentina
- 8.7.6.1. Argentina: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.7.6.2. Argentina: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.7.6.3. Argentina: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.7. Gaucher Disease Treatment Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Amicus Therapeutics, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. CANbridge Life Sciences Ltd.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Eli Lilly and Company
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Johnson & Johnson, Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Lingyi Biotechnology
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Protalix Biotherapeutics Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Sanofi
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Spur Therapeutics
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Takeda Pharmaceutical
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
